Milos Dokmanovic

A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

Bey-Dih Chang, Eugenia V. Broude, Milos Dokmanovic et al. · PubMed · 1999 · 546 citations

Slp Markers, Pathology, Cell Proliferation +20

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

Johanna Ungerstedt, Yoshihiro Sowa, Weili Xu et al. · Proceedings of the National Academy of Sciences · 2005 · 504 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +20

Histone sumoylation is a negative regulator in <i>Saccharomyces cerevisiae</i> and shows dynamic interplay with positive-acting histone modifications

Dafna Nathan, Kristin Ingvarsdottir, David E. Sterner et al. · Genes & Development · 2006 · 325 citations · Full text

Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor

Weisheng Xu, Lang Ngo, Gisela Perez et al. · Proceedings of the National Academy of Sciences · 2006 · 179 citations · Full text

Apoptosis, Cell Death, Reactive Oxygen Species +17

Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers

Nishant Mohan, Jiangsong Jiang, Milos Dokmanovic et al. · Antibody Therapeutics · 2018 · 150 citations · Full text

Trastuzumab-mediated Cardiotoxicity, Trastuzumab Intervention, Oncology +15